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Pathogens and cellular danger signals activate sen-
sors such as RIG-I and NLRP3 to produce robust
immune and inflammatory responses through
respective adaptor proteins MAVS and ASC, which
harbor essential N-terminal CARD and PYRIN
domains, respectively. Here, we show that CARD
and PYRIN function as bona fide prions in yeast
and that their prion forms are inducible by their
respective upstream activators. Likewise, a yeast
prion domain can functionally replace CARD and
PYRIN in mammalian cell signaling. Mutations in
MAVS and ASC that disrupt their prion activities in
yeast also abrogate their ability to signal in mamma-
lian cells. Furthermore, fibers of recombinant PYRIN
can convert ASC into functional polymers capable
of activating caspase-1. Remarkably, a conserved
fungal NOD-like receptor and prion pair can function-
ally reconstitute signaling of NLRP3 and ASCPYRINs
in mammalian cells. These results indicate that
prion-like polymerization is a conserved signal
transduction mechanism in innate immunity and
inflammation.
INTRODUCTION
The innate immune system is an evolutionarily conserved self-
defense mechanism that relies on germline encoded pattern
recognition receptors to distinguish ‘‘self’’ from ‘‘nonself’’ signals
(Takeuchi and Akira, 2010). Although the Toll-like receptors sur-
vey the endosomes and extracellular milieu, cyclic GMP-AMP
synthase (cGAS) and retinoic acid-induced gene-I (RIG-I)-like re-
ceptors (RLRs) detect cytosolic DNA and aberrant RNA, respec-
tively, to trigger a robust innate immune response (Sun et al.,
2013; Wu et al., 2013; Yoneyama et al., 2004). RIG-I, upon bind-
ing to 50-triphosphorylated RNA and lysine 63 (K63)-linked poly-
ubiquitin chains, activates the adaptor protein MAVS that wasrecently shown to have biochemical properties of prions (Hou
et al., 2011; Zeng et al., 2010). Specifically, after viral infection,
MAVS forms detergent-resistant, high-molecular-weight poly-
mers capable of activating the downstream transcription factors
NF-kB and IRF3. Remarkably, active MAVS fibers can catalyze
similar biochemical changes in inactiveMAVS. These newly con-
verted MAVS molecules gain the ability to activate the down-
stream signaling cascades.
MAVS is unique as a gain-of-function and beneficial prion. It
harbors an N-terminal CARD (MAVSCARD) that serves as its prion
domain. Mutations in CARD that abolish MAVS polymerization
also prevent virus-induced, RIG-I-dependent IRF3 activation
(Liu et al., 2013). CARD belongs to the death domain (DD) super-
family that also includes the DD, DED, and PYRIN subfamilies
(Park et al., 2007a). Like CARD, members of the DD superfamily
regulate cell signaling through homotypic interactions and the
formation of oligomeric complexes.
The inflammasome is another notable DD containing signaling
complex, which is activated as a result of cellular infection or
damage and is implicated in numerous diseases (Schroder and
Tschopp, 2010). ASC is an adaptor protein for inflammasome
signaling. It is composed of a PYRIN domain (ASCPYD) at the N
terminus and a CARD (ASCCARD) at the C terminus. ASCPYD in-
teracts with PYRINs of activated upstream proteins such as
NLRP3 and AIM2, whereas ASCCARD then relays the signal
downstream by binding to the CARD of procaspase-1, leading
to caspase-1 activation. Activated caspase-1 then cleaves itself
and pro-IL-1b, forming p10 and p17 products, respectively. In
response to stimulation, ASC forms high-molecular-weight
oligomers that can be visualized as perinuclear clusters by mi-
croscopy (Martinon et al., 2002). However, the molecular
composition of the inflammasome and the mechanism of ASC
activation remain unclear. Similarly, MAVS and ASC are both
death-domain-containing adaptors that relay signals from multi-
ple upstream sensors to downstream effectors, eventually lead-
ing to the secretion of protective cytokines (Figure S1A available
online).
To further understand MAVS prion conversion and to investi-
gate if other DD-containing proteins also possess prion-like
properties, we sought to reconstitute the prion properties ofCell 156, 1207–1222, March 13, 2014 ª2014 Elsevier Inc. 1207
Figure 1. MAVSCARD and Sup35NM Functionally Replace Each Other in Yeast and Mammalian Cells
(A) Cartoon depictions of MAVS, Sup35, MAVSCARD-Sup35C, and NM-MAVS proteins.
(B) Cells from a single yeast colony harboring constitutively expressed MAVSCARD-Sup35C and galactose-inducible (GAL-)MAVSCARD-EYFP (Ura+) were grown
for 48 hr in media containing either galactose (SG-ura) or glucose (SD-ura), followed by plating onto 1/4YPD at a density of 500 cells/plate. In this and sub-
sequent panels, induction of EYFP-tagged protein was monitored by western blotting with a GFP antibody.
(C) Single yeast colonies harboring constitutively expressed MAVSCARD-Sup35C and GAL-NM-EYFP or GAL-MAVSCARD-EYFP (Ura+) were grown in SD-ura for
24 hr to equal density followed by growth in SG-ura for 48 hr. Two colonies of each were plated onto non-prion-selective media (SD-ura) and prion-selective,
adenine-deficient media (SD-ade) at 5-fold serial dilutions. In this and subsequent figures, one dilution on SD-ura is shown as an indicator of equal plating density
among the samples. Dotted red line in this and other figures indicates serial dilutions grown nonadjacently on the same plate.
(D) Left: a schematic for the cytoduction experiments. Ade+ or ade donor strain harboring death domain (DD)-Sup35C fusion (e.g., MAVSCARD-Sup35C) was
cytoduced into a r recipient strain expressing the same DD-Sup35C fusion and a kar1mutation (kar1-15), which prevents nuclear fusion. Haploid cytoductants,
(legend continued on next page)
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MAVSCARD and other DDs in yeast, using the Sup35-based prion
assay (Alberti et al., 2009). Sup35 harbors a low-complexity,
intrinsically disordered prion domain (NM) and a globular, cata-
lytic domain (Sup35C) that terminates translation. In its prion
state, NM forms amyloid-like fibers that sequester the Sup35
protein in an insoluble aggregate, resulting in a reduction in
translation termination and a corresponding increase in stop
codon readthrough that is readily visualized phenotypically.
The modular nature of the NM and Sup35C domains, as well
as the availability of phenotypic reporters for Sup35 activity,
has popularized the Sup35-based yeast prion assay (Alberti
et al., 2009; Osherovich et al., 2004).
In this report, we use genetic and biochemical assays to
demonstrate that MAVS and ASC form prions in yeast in
response to upstream sensors and that their prion conversion
is necessary for their immune and inflammatory signaling abili-
ties. We further show that recombinant ASCPYD forms prion-
like fibers capable of converting inactive ASC into an active prion
form necessary and sufficient for downstream signaling. Finally,
we demonstrate that homologous domains of a conserved NOD-
like receptor and a bona fide prion from a filamentous fungus can
together functionally replace NLRP3 and ASC PYRINs in
mammalian inflammasome signaling, suggesting that prion-like
polymerization is an evolutionarily conserved mechanism of
signal transduction.
RESULTS
MAVSCARD and Sup35NM Functionally Replace Each
Other in Yeast and Mammalian Cells
We recently showed that MAVSCARD forms fibers that can
convert endogenous MAVS into high-molecular-weight, SDS-
resistant polymers capable of activating IRF3 (Hou et al.,
2011). To determinewhetherMAVS has other defining properties
of prions, we employed the Sup35-based yeast prion assay. We
fusedMAVSCARD to Sup35C and constitutively expressed the re-
sulting fusion protein in a yeast strain that lacks endogenous
Sup35 and contains a premature stop codon in ADE1, a gene
critical for de novo adenine biosynthesis (Figure 1A; Table S1).
Through the activity of soluble Sup35C, the nonsense ADE1mu-
tation blocks the synthesis of functional Ade1, resulting in the
accumulation of a red pigment when grown on rich media
(1/4YPD) and an inability to grow on media lacking adenine
(-ade). When Sup35 activity is compromised, as when it forms
a prion, the stop codon is read through, resulting in the synthesiscontaining both parental cytoplasms but only the recipient nucleus, were selected
or resultant cytoductants each expressingMAVSCARD-Sup35Cwere plated onto 1
from Ade+ or ade MAVSCARD-Sup35C donors.
(E) Left: a schematic for the mating and plasmid shuffle experiments. Ade+ or ade
Leu+ plasmid (black circle) were mated with an adeMATa strain harboring DD-Su
lost the original DD-Sup35C Leu+ plasmid. The resultant leu Trp+ diploids we
MAVSCARD-Sup35C was mated with an ade MATa strain harboring either MA
Representative single colonies of leu Trp+ diploids were plated onto 1/4YPD an
(F) Mitochondrial fractions from parental 293T cells or those expressing NM-MAV
assay. Dimerization of IRF3 was visualized by autoradiography following native g
(G) NM-flag or NM-MAVS was transfected into 293T-IFNb-luciferase reporter ce
allowed to incubate for an additional 24 hr, followed by luciferase reporter assay
See also Figure S1.of full-length Ade1, a concomitant loss of the red pigment, and
growth on -ade media (Figure S1B).
The cells expressing MAVSCARD-Sup35C were red on 1/4YPD
and were unable to grow on -ade media, indicating that the
fusion protein was adequately expressed and fully functional.
The frequency of prion switching depends on the concentration
of the prion protein. Consequently, a defining hallmark of prions
is that the prion state can be induced by transient overexpres-
sion of the prion protein. To this end, we transformed the
MAVSCARD-Sup35C strain with a plasmid driving the expression
of MAVSCARD-EYFP from the inducible GAL1 promoter.
Following transient expression of MAVSCARD-EYFP in galac-
tose-containing media, we plated the cells to glucose-contain-
ing, nonselective media. This treatment produced white and
red/white sectored colonies on 1/4YPD, indicating a self-perpet-
uating state that is stable over numerous cell divisions and
unlikely to be due to genetic mutations (Figures 1B and S1C).
Similarly, when plated to adenine deficient glucose-containing
medium (SD-ade), the transient expression of MAVSCARD-
EYFP, but not NM-EYFP, produced a high frequency of Ade+ col-
onies, each derived from a cell that had heritably acquired the
ability to synthesize adenine (Figure 1C). We estimated that
transient expression of MAVSCARD increased the frequency of
Ade+ colonies by 125-fold.
To determine whether the Ade+ phenotype of MAVSCARD-
Sup35C yeast is cytoplasmically inherited, we performed a
series of cytoduction experiments, in which the cytoplasm, but
not the nucleus, is transferred from one yeast strain (donor) to
another (recipient). The recipient contains a kar1 mutation that
blocks nuclear fusion. Haploid daughter cells (cytoductants)
are subsequently recovered that have lost the donor nucleus
but now contain cytoplasm from both parents (Figure 1D).
When an Ade+ donor was cytoduced with an ade recipient
(both expressingMAVSCARD-Sup35C), over 40%of the cytoduc-
tants were Ade+, indicating that the Ade+ phenotype is inherited
cytoplasmically without nuclear contribution (Figure 1D). Cyto-
duction between two ade strains uniformly produced ade
cytoductants.
To assess whether the Ade+ phenotype is dominant and
dependent on MAVSCARD-Sup35C, we performed a series of
plasmid shuffle experiments (Figure 1E). First, we mated haploid
Ade+ cells of mating type a (MATa) with haploid ade cells of
MATa. The two strains each expressed MAVSCARD-Sup35C
from differently marked plasmids (Leu+ or Trp+). We then as-
sayed Sup35C function in diploids that had lost the original. Middle: representative single clones of Ade+ or ade donors, ade recipients,
/4YPD and SD-ade. Right: a table showing the frequency of Ade+ cytoductants
 haploid yeast of mating type a (MATa) expressing DD-Sup35C fusion from a
p35C on a Trp+ plasmid (red circle), followed by selection for diploids that have
re assessed for the prion phenotype. Right: an ade or Ade+ MATa strain of
VSCARD-Sup35C or ASCPYD-Sup35C following the protocol outlined above.
d SD-ade. Lanes are numbered as described in the text.
S were incubated with NM or PrP fibers as indicated followed by in vitro IRF3
el electrophoresis.
lls. Recombinant NM fibers were added to the culture media 24 hr later and
. Error bar represents SD of triplicates.
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Figure 2. MAVSCARD-Sup35C Prion Assay Faithfully Recapitulates RIG-I-Dependent MAVS Activation and Reveals Stepwise Polymerization
of MAVSCARD in Yeast
(A) A single yeast colony harboring constitutively expressedMAVSCARD-Sup35C andGAL-RIG-I(N)-EYFP (Ura+) was grown in SD-ura (top) or SG-ura (bottom) for
48 hr followed by plating onto 1/4YPD at a density of 500 cells/plate.
(legend continued on next page)
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MAVSCARD-Sup35C construct of the Ade+ MATa parent. The
resultant leu, Trp+ diploids retained a pink color and the ability
to grow on SD-ade, indicating that the Ade+ phenotype is
dominant (Figure 1E, lane 2). As a control, mating between
two ade strains resulted in red cells that did not grow on
SD-ade (Figure 1E, lane 1). However, when either Ade+ or ade
MAVSCARD-Sup35C yeast were mated with an ade haploid ex-
pressing an unrelated DD-Sup35C fusion (ASCPYD-Sup35C), the
resultant diploids that had lost the MAVSCARD-Sup35C plasmid
were red and ade (spontaneous Ade+ papilla of ASCPYD-
Sup35C are described below), indicating that the Ade+ pheno-
type requires the continued expression of MAVSCARD-Sup35C.
We conclude that MAVSCARD is a bona fide prion protein in yeast
and designate its prion state [MAVSCARD+] and its native (prion
minus) state [mavscard-], with capitals and brackets denoting
genetic dominance and cytoplasmic inheritance, respectively.
The [MAVSCARD+] phenotype is similar to that of yeast containing
the prion form of wild-type (WT) Sup35, [PSI+] (Figure S1D).
Given that MAVSCARD functionally replaces Sup35NM as a
yeast prion, we tested whether substituting MAVSCARD with
NM (NM-MAVS, Figure 1A) could activate IRF3 in the mamma-
lian system. We recently described a cell-free system that reca-
pitulates MAVS-polymer-dependent IRF3 activation, where
incubation of MAVSCARD fibers with mitochondria (containing
MAVS), along with cytosolic extracts and 35S-IRF3 substrate
results in IRF3 dimerization, the hallmark of its activation (Fig-
ure S1E). Here, only the incubation of NM fibers with NM-
MAVS containing mitochondria resulted in IRF3 dimerization
(Figures 1F and S1E). Next, to determine whether NM-MAVS
could signal in cells, we added NM fibers, which can enter
mammalian cells (Ren et al., 2009), to the culture media of
293T-IFNb-luciferase reporter cells transfected with either NM
or NM-MAVS. Luciferase activity assay showed that NM fibers
markedly enhanced IFNb induction in cells expressing NM-
MAVS, but not in those expressing NM (Figure 1G). Together,
these data indicate that NM fibers induce a specific conforma-
tional switch in NM-MAVS that is sufficient for downstream
IRF3 activation.
MAVSCARD-Sup35C Prion Assay Faithfully Recapitulates
RIG-I-Dependent MAVS Activation and Reveals
Dynamics of MAVSCARD Prion Conversion in Yeast
In mammalian cells, overexpression of the N-terminal tandem
CARDs of RIG-I [RIG-I(N)] is sufficient to activate MAVS (Seth
et al., 2005). To determine whether RIG-I could trigger MAVS
prion conversion in yeast, we transiently expressed RIG-I(N) in(B) Single yeast colonies harboring MAVSCARD-Sup35C and NM- or RIG-I(N)-EYF
before plating of two independent colonies at 5-fold serial dilutions onto SD-ade
grown under the same conditions on separate plates in the same experiment.
(C) Similar to (B), except single yeast colonies harbored constitutively expresse
MAVSCARD-Sup35C was monitored using a Sup35C antibody.
(D) Similar to (C), except that cells were plated onto 1/4YPD at a density of 500 c
(E) Mitochondrial fractions from parental 293T cells were incubated at RT with lysa
assay. Dimerization of IRF3 was visualized by autoradiography following nati
nonadjacent samples on the same gel. Irrelevant lanes were removed for clarity.
(F) Similar to (B), except cells expressed WT or mutant GAL-MAVSCARD-EYFP.
(G) Similar to (C), except cells expressed GAL-MAVSCARD-EYFP and were plated
See also Figure S2.the MAVSCARD-Sup35C strain. Expression of RIG-I(N) resulted
in a high frequency of white colonies on 1/4YPD and a 3,000-
fold increase in the frequency of Ade+ colonies as compared to
expression of NM (Figures 2A and 2B). The much higher fre-
quency of prion conversion induced by RIG-I(N) as compared
to MAVSCARD suggests that the physiological upstream sensor
is more potent at nucleating MAVSCARD polymerization. Instead
of forming self-perpetuating fibers, RIG-I(N) forms a tetramer in
the presence of K63 polyubiquitin chains (Jiang et al., 2012).
Consistent with RIG-I’s role as an upstream prion-nucleating
factor rather than a prion itself, transient expression of RIG-I(N)
was unable to induce Ade+ colonies in cells harboring RIG-I(N)-
Sup35C (Figure S2).
Recently, we identified a number of conserved MAVSCARD
residues that, when mutated to alanine, abolished virus-induced
IRF3 activation (Liu et al., 2013). Consistent with their inability
to signal in the mammalian system, E26A, R64A, and R65A
MAVSCARD-Sup35C were defective in RIG-I(N)-induced prion
formation (Figures 2C and 2D). Surprisingly, however, when
we incubated 293T lysate expressing WT or mutant
MAVSCARD with mitochondria from parental 293T cells (Fig-
ure S1E, left), only R65A andR64A/R65AMAVSCARDwere defec-
tive in inducing endogenous MAVS to activate IRF3 in vitro
(Figure 2E).
Unlike amorphous protein aggregation, prions polymerize in
an ordered process that proceeds through a rate-limiting nucle-
ation step followed by rapid, energetically favorable polymeriza-
tion (Serio et al., 2000). The Sup35-based yeast prion assay can
uncouple the effects of prion nucleation, mediated by transient
expression of the inducing protein, and polymerization, where
prion seeds are perpetuated by the Sup35C fusion protein that
is responsible for the phenotypic readout. Consistent with our
in vitro assay in Figure 2E, only R65A MAVSCARD failed to induce
MAVSCARD-Sup35C prion conversion in yeast (Figure 2F), sug-
gesting that R65A is unable to nucleate WT MAVS prion conver-
sion, whereas E26A and R64A have no nucleation defect.
However, all three mutants of MAVSCARD-Sup35C were unable
to propagate as prions when supplied with prion templates in
the form of transiently expressed WT MAVSCARD-EYFP (Fig-
ure 2G), suggesting that each of these mutations abrogates
MAVS polymerization. These results indicate that MAVS
nucleation alone is insufficient to activate the downstream
signaling cascades. Rather, MAVS polymerization is required
for downstream signaling. Thus, as for other prions, MAVSCARD
prion formation is a multistep process comprising sepa-
rable nucleation and polymerization steps. Together with ourP were grown in SD-ura to equal density followed by growth in SG-ura for 48 hr
and SD-ura. The solid red line in this and other figures indicates serial dilutions
d WT or mutant MAVSCARD-Sup35C and GAL-RIG-I(N)-EYFP. Expression of
ells/plate.
tes of 293T cells expressingWT or mutant MAVSCARD, followed by in vitro IRF3
ve gel electrophoresis. Dotted black line in this and other panels indicates
at a density of 50,000 cells per plate.
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previous report, these results firmly establish MAVS as a bona
fide prion and validate the Sup35-based yeast prion assay
as an attractive means for identifying and characterizing other
prions.
Characterization of ASCPYD as a Prion Domain
To identify other DD superfamily members that may behave as
prions, we used the Sup35 system to screen 18 additional
DDs, spanning all four subfamilies (Figure S3A; Table S2).
Several of the DD-Sup35C strains exhibited uniform white colors
on 1/4YPD, indicating a high basal level of stop codon read-
through due to insufficient expression or low basal activity of
the fusion protein. Of the remaining strains, the one expressing
ASCPYD-Sup35C formed predominantly dark red colonies with
an appreciable frequency of white colonies (Figure S3B), sug-
gesting that ASCPYD-Sup35C sufficiently rescues WT Sup35
function and also exhibits a strong tendency for prion formation.
To explore the putative prion properties of ASC, we transiently
expressed ASCPYD-EYFP in a red ASCPYD-Sup35C isolate.
Remarkably, this increased the appearance of Ade+ colonies
and both white andwhite/red sectored colonies on 1/4YPD, sug-
gesting that ASCPYD behaves as a functional prion domain in
yeast (Figures 3A, S3C, S3D). To determine whether ASC prion
conversion can be induced by upstream sensors, we investi-
gated the prion conversion of ASCPYD-Sup35C upon transient
expression of NLRP3PYD or AIM2, which is known to activate
the inflammasome in mammalian cells. Transient NLRP3PYD or
AIM2 expression indeed increased the frequency of white and
Ade+ colonies (Figures 3B and 3C). Interestingly, the effect
from these proteins was much stronger than had been observed
for ASCPYD-induced prion conversion. Moreover, AIM2 was un-
able to induce prion formation in ASCCARD-Sup35C strains,
consistent with ASC activation through ASCPYD and AIM2PYD
interaction (Figure 3D). IFI16 and IFI204 also harbor N-terminal
PYRINs; however, they were unable to induce prion switching
of ASCPYD (Figure S3E). Similarly, a strain harboring
NLRP3PYD-Sup35C was unable to undergo prion conversion
following ASCPYD, NLRP3PYD, or AIM2 expression (Figure S3F).
Together, these results demonstrate that the physiological up-
stream signaling proteins of ASCPYD nucleate prion formationFigure 3. ASCPYD Behaves as a Prion in Yeast and Can Be Functionally
(A) A single yeast colony harboring constitutively expressed ASCPYD-Sup35C and
by plating onto SD-ade and 1/4YPD at a density of 100,000 and 500 cells/plate,
(B) Similar to (A), except that NLRP3PYD or AIM2, instead of ASCPYD, was used t
(C) GAL-inducible protein expression in (A) and (B) is monitored by immunoblott
(D) Single yeast colonies with constitutively expressed ASCPYD-Sup35C or ASCC
followed by plating of 5-fold serial dilutions onto SD-ade and SD-ura. One serial
(E) Left: following cytoduction as depicted in Figure 1D, representative single clo
expressing ASCPYD-Sup35Cwere plated onto 1/4YPD or SD-ade. Right: a table sh
ASCPYD-Sup35C.
(F) Mating between an ade or Ade+ MATa strain with an ade MATa strain ea
Figure 1E. Representative resultant diploid leu Trp+ single colonies were plated
(G) Following induction by AIM2 expression, colonies with soluble or prion form
analysis for SDS-resistant polymers and SDS-PAGE for expression levels.
(H) Cell lysates from NM-ASCPYD- or NM-ASCCARD-transfected 293T cells were
western analysis for caspase-1 activation.
(I) NM fibers were added to the culturemedia of NM-ASCPYD- or NM- ASCCARD-tra
immunoblotting analysis of secreted IL-1b (p17) and pro-IL-1b.
See also Figure S3.more potently than the prion domain itself, but are not prions
themselves.
Next, to investigate the mode of inheritance of the Ade+
phenotype, we performed cytoduction experiments as de-
scribed in Figure 1D with strains harboring ASCPYD-Sup35C.
Ade+, but not ade, donor strains produced haploid cytoduc-
tants that were Ade+ and white on 1/4YPD, indicating that the
Ade+ phenotype of ASCPYD-Sup35C is cytoplasmically inherited
(Figure 3E). Furthermore, mating between Ade+ and ade yeast
followed by a plasmid shuffle as described in Figure 1E resulted
in uniformly Ade+ diploids, and the Ade+ phenotype required the
continued presence of the ASCPYD-Sup35C plasmid (Figure 3F,
lanes 2 and 4). No Ade+ yeast was observed after crossing two
ade strains (lane 1). These results indicate that the Ade+ pheno-
type of ASCPYD-Sup35C is dominant, requires the continuous
expression of ASCPYD-Sup35C, and cannot be transmitted to
MAVSCARD. Taken together, we conclude that ASCPYD acquires
a prion state in yeast, which we hereafter designate [ASCPYD+].
To confirm that ASCPYD had undergone a conformational switch
in the [ASCPYD+] cells, we performed semidenaturing detergent-
agarose gel electrophoresis (SDD-AGE), a technique commonly
used to detect SDS-resistant polymers of prion proteins (Half-
mann and Lindquist, 2008). We had previously employed the
SDD-AGE assay to show that activated MAVS forms high-
molecular-weight polymers (Hou et al., 2011). Similarly, SDD-
AGE analysis revealed that [ASCPYD+], but not [ascpyd-] cells,
harbor SDS-resistant polymers of ASCPYD-Sup35C, as detected
with a Sup35C antibody (Figure 3G).
Next, we tested whether the NM prion domain from Sup35
could functionally replace ASCPYD in activating caspase-1.
Together with lysate from 293T cells stably expressing procas-
pase-1 (293T+procaspase-1) as the substrate, incubation of
recombinant NM fibers with lysate from 293T cells expressing
NM-ASCCARD, but not NM-ASCPYD fusion, resulted in caspase-1
activation in vitro (Figure 3H). Moreover, the addition of NM fibers
to 293T cells stably expressing procaspase-1, pro-IL-1b, and
NM-ASCCARD resulted in the secretion of active IL-1b, p17 (Fig-
ure 3I). In contrast, the cells expressing NM-ASCPYD did not
activate the inflammasome. Hence, a yeast prion domain can
functionally replace ASCPYD in inflammasome signaling. FromSubstituted by the NM Prion Domain in Mammalian Cells
GAL-ASCPYD-EYFP (Ura+) was grown in SD-ura or SG-ura for 2 days followed
respectively.
o induce ASCPYD prion formation.
ing with a GFP antibody.
ARD-Sup35C and GAL-AIM2-EYFP were grown in SD-ura or SG-ura for 2 days
dilution on SD-ura is shown.
nes of Ade+ or ade donors, ade recipients, and resultant cytoductants each
owing the frequency of Ade+ cytoductants fromAde+ or ade donors harboring
ch harboring differently marked DD-Sup35C was carried out as depicted in
onto 1/4YPD or SD-ade.
of ASCPYD ([ascpyd-] or [ASCPYD+], respectively) were subjected to SDD-AGE
incubated with NM fibers and lysates containing procaspase-1 followed by
nsfected 293T cells stably expressing procaspase-1 and pro-IL-1b, followed by
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these results, we conclude that ASC undergoes a prion-like
switch to activate downstream signaling.
ASCPYD Mutants that Disrupt Its Prion Activity Are
Defective in Inflammatory Signaling
ASCPYD shares the same overall six a-helical bundle structure
that is the hallmark of the DD superfamily (Ferrao and Wu,
2012). Structural analysis of ASCPYD and NLRP3PYD revealed a
strong dipole moment created by adjacent positively and nega-
tively charged surface patches, suggesting that electrostatic in-
teractions may play a role in PYRIN-PRYIN interaction (Liepinsh
et al., 2003). Mutations of a number of conserved, surface-
exposed ASCPYD residues have been shown to be defective in
binding to ASC and NLRP3, without affecting protein folding as
observed by nuclear magnetic resonance (Vajjhala et al.,
2012). To investigate the consequence of ASC prion formation
on its signaling abilities, we tested mutants at several conserved
charged and hydrophobic residues (R41A, D48A, and P40A) in
our yeast prion assay and for their ability to generate mature
caspase-1 and IL-1b in mammalian cells. In yeast, transient
NLRP3PYD expression led to the prion conversion of WT and
P40A ASCPYD, but not R41A or D48A ASCPYD (Figure 4A), sug-
gesting ASC R41A and D48A to be defective in inflammasome
signaling. In 293T cells, the NLRP3 inflammasome pathway
has been reconstituted through the exogenous expression of
NLRP3, ASC, and procaspase-1, components not normally ex-
pressed in 293T cells (Agostini et al., 2004). To test the signal-
dependent activation of ASC in cells, we transfected ASC WT
or mutants in 293T cells stably expressing NLRP3, procas-
pase-1, and pro-IL-1b and then subjected the cells to a time
course of treatment with Nigericin, a chemical known to strongly
activate NLRP3. Inflammasome activation was monitored
through the cleavage of procaspase-1 and the secretion of cas-
pase-1 (p10) and IL-1b (p17) into the culture supernatant.
Consistent with NLRP3PYD-dependent prion conversion in yeast,
we observed caspase-1 activation and secretion of p10 and p17
only in ASC WT- or P40A-expressing cells, whereas ASC R41A
and D48A were defective (Figure 4B).
To investigate the mechanism of the observed signaling
defect, we tested homotypic interactions between the WT and
mutant ASCPYDs, which may be different from its interactions
with PYRINs of upstream sensors. To this end, we first examined
whether the expression of mutant ASCPYD could induce prion
switching in WT ASCPYD-Sup35C cells. Conversely, we also
tested whether WT ASCPYD could induce prion conversion in
cells containingmutant ASCPYD-Sup35C. Interestingly, we found
that the mutants behaved similarly in both assays. Namely,
ASCPYD R41A and D48A could neither induce prion conversion
of WT ASCPYD-Sup35C nor could they be induced to form prions
themselves (Figures 4C and 4D). P40A behaved similarly to the
WT protein in both assays. These results suggest that, as a
part of their respective positive and negative patches, R41 and
D48 mediate essential interactions necessary for both the nucle-
ation and polymerization of ASC.
ASC activates caspase-1 in vitro when cells expressing both
proteins are lysed in a low-salt buffer (Martinon et al., 2002). Tak-
ing advantage of this ASC-dependent caspase-1 activity assay,
we transiently expressed ASC WT, R41A, D48A, and P40A in1214 Cell 156, 1207–1222, March 13, 2014 ª2014 Elsevier Inc.293T cells. Lysates from 293T cells expressing ASC and those
stably expressing procaspase-1 and pro-IL-1b were incubated
at 30C for 45 min. Western blot analysis for active subunits of
caspase-1 (p10) and IL-1b (p17) indicated that both ASC WT
and P40A robustly activated caspase-1 and IL-1b in vitro,
whereas the R41A andD48Amutants that were defective in prion
formation in yeast were also defective in activating caspase-1
and IL-1b (Figure 4E). Collectively, these data demonstrate that
ASC mutants unable to form self-perpetuating prions in yeast
are also incapable of activating the inflammasome, suggesting
that prion formation is necessary for ASC activity.
Reconstitution of Inflammasome Signaling in Yeast
Reveals Caspase-1 Activation Only in Colonies with ASC
Prions
Next, we generated a strain of yeast expressing full-length ASC
(ASCFL)-Sup35C in place of endogenous Sup35 and tested for
ASCFL prion conversion after transient expression of AIM2,
NLRP3PYD, and WT or mutant ASCPYD (Figure S4A). AIM2 and
NLRP3PYD induced a >200-fold increase in Ade+ colonies on
SD-ade and the appearance of white colonies on 1/4YPD (Fig-
ures 5A and 5B). Moreover, ASCPYD mutants that were defective
in prion formation were also defective in the context of full-length
ASC (Figures 5A and S4B). SDD-AGE analysis revealed that
ASCFL-Sup35C had acquired SDS-resistant polymers in the
Ade+ isolates (designated [ASCFL+]), but not in the ade isolates
([ascfl]) (Figure 5C). These results indicate that AIM2 and
NLRP3 induced ASCFL to convert to a self-perpetuating prion
form.
We then applied our phenotypic assay to test if caspase-1 and
NLRC4, which harbor N-terminal CARDs but no PYRIN domains,
could induce ASC prion conversion. As an important inflamma-
some sensor for bacterial flagellin and type III secretion systems,
NLRC4 can directly activate caspase-1, but this activity is mark-
edly enhanced in the presence of ASC (Broz et al., 2010). When
expressed in yeast, a C284A active site mutant caspase-1 was
unable to induce ASC (PYRIN, CARD, or full length)-Sup35C
yeast to form Ade+ colonies (Figure S4C). However, expression
of NLRC4CARD induced ASCFL-Sup35C, but not ASCPYD- or
ASCCARD-Sup35C, prion conversion, and this effect was abol-
ished in yeast harboring ASCFL-Sup35C R41A or D48A polymer-
ization mutants (Figure S4D). These results suggest that
NLRC4CARD is able to switch ASCFL into a prion through
CARD-CARD interactions, but this conversion is strictly depen-
dent on ASCPYD-mediated polymerization. Despite its ability to
also interact with ASCCARD, caspase-1 cannot induce ASCFL
polymerization.
ASCFL-Sup35C can be used to reconstitute inflammasome
signaling in 293T cells, suggesting that the protein retains the
inflammasome signaling activity of WT ASC (Figure S4E).
Next, to reconstitute caspase-1 activation in yeast, cells har-
boring ASCFL-Sup35C were transformed with constitutively ex-
pressed procaspase-1 along with galactose-inducible AIM2 or
NLRP3PYD (Figure 5D). Transient expression of either AIM2 or
NLRP3PYD led to the appearance of white colonies on 1/4YPD
similar to those observed in yeast without caspase-1 (data not
shown). Further passaging of these white colonies revealed an
appreciable rate of switching back to the red phenotype, which
Figure 4. ASC Mutants Defective in Prion Formation Are Defective in Inflammasome Signaling
(A) Individual yeast colonies constitutively expressing WT or mutant ASCPYD-Sup35C and GAL-NLRP3PYD-EYFP were grown in SD-ura or SG-ura for 2 days,
followed by plating of 5-fold serial dilutions onto SD-ura and SD-ade.
(B) Nigericin was added to ASCWT- or mutant-transfected 293T cells stably expressing NLRP3, procaspase-1, and pro-IL-1b, followed by western blot analysis
of cell lysates for caspase-1 processing and of culture supernatants for active caspase-1 (p10) and IL-1b (p17) secretion. Dotted black line in this and other panels
indicates nonadjacent samples on the same gel. Irrelevant lanes were removed for clarity.
(C) Similar to (A), except that WT or mutant ASCPYD, instead of NLRP3PYD, was used to induce ASCPYD prion conversion.
(D) Individual colonies constitutively expressing WT or mutant ASCPYD-Sup35C and WT GAL-ASCPYD-EYFP were treated as in (A).
(E) Lysates of 293T cells expressing WT or mutant ASC were incubated with procaspase-1 and pro-IL-1b containing cell extracts, followed by analysis of
caspase-1 and IL-1b cleavage by western blotting.is indicative of a bistable, epigenetically inherited trait (Figure 5E).
We then used a colony lysis procedure to assess caspase-1
activation in individual colonies (Kushnirov, 2000). Strikingly,
we observed procaspase-1 cleavage only in [ASCFL+], but not
[ascfl], colonies, despite their having originated from the
same [ASCFL+] colony (Figure 5F). Altogether, these results
strongly suggest that ASC prion formation and propagation are
necessary and sufficient for downstream signaling.Recombinant ASCPYD Fibers Convert Inactive ASC into a
High-Molecular-Weight Form Capable of Downstream
Signaling
Mammalian PrP and yeast prions typically adopt fibrous struc-
tures that perpetuate protein-based forms of inheritance
(Toyama and Weissman, 2011). To investigate whether the prion
domain of ASC exhibits similar properties, ASCPYD (N1-90) was
expressed in E. coli and purified under native conditions toCell 156, 1207–1222, March 13, 2014 ª2014 Elsevier Inc. 1215
Figure 5. Reconstitution of Inflammasome Signaling in Yeast Reveals Caspase-1 Activation Only in Colonies Containing ASC Prions
(A) Single colonieswith constitutively expressed ASCFL-Sup35C andGAL-inducible NM, NLRP3PYD, AIM2,WT, or mutant ASCPYDwere grown in SD-ura for 24 hr,
followed by incubation in SG-ura for 2 days. Five-fold serial dilutions were then plated onto SD-ade and SD-ura.
(B) Similar to (A) except that cells were plated to 1/4YPD at 500 cells/plate.
(C) Following induction of Ade+ by AIM2 expression, colonies with soluble or prion form of ASCFL-Sup35C ([ascfl] or [ASCFL+], respectively) were subjected to
SDD-AGE analysis for SDS-resistant aggregates and SDS-PAGE for expression levels.
(D–F) Schematic for the reconstitution of inflammasome signaling in yeast (D). Yeasts expressing AIM2- or NLRP3PYD-EYFP from a GAL-inducible promoter
(Ura+), ASCFL-Sup35C from the constitutive TEF promoter, and procaspase-1 from the constitutive SUP35 promoter were grown in galactose containing media
for 2 days. The resultant [ASCFL+] colonies were restreaked onto 1/4YPD (E), from which individual [ascfl] or [ASCFL+] colonies were lysed and subjected to
western analysis for caspase-1 activation (F).
See also Figure S4.apparent homogeneity. Negative-stain electron microscopy
analysis of the protein revealed that ASCPYD assembled into
fibers with a weakly scattering center, suggestive of symmetry
about a central axis (Figure 6A).
The defining property of prions is an ability to convert native
species of the protein into a polymerized, infectious form
(Prusiner, 1998). To determine whether ASCPYD fibers can
induce a similar conversion of native ASC protein, we first sought
conditions that would separate polymerized and native forms of
ASC. Using a sucrose density gradient, we fractionated lysate
from 293T cells stably expressingNLRP3 andASCFL-GFP before
and after Nigericin treatment. Nigericin treatment resulted in the1216 Cell 156, 1207–1222, March 13, 2014 ª2014 Elsevier Inc.formation of large ASC particles that sedimented to the bottom
of a 20%–60% sucrose gradient (Figure 6B, top). When incu-
bated with lysate from 293T cells stably expressing procas-
pase-1, only the high-molecular-weight (MW) fractions were
capable of activating caspase-1, suggesting that the active
form of ASC consists of large ASC particles (Figure 6B, bottom).
We then incubated a substoichiometric amount of ASCPYD fibers
with ASCFL-GFP (1:10,000 molar ratio) and observed a notable
shift of ASC from a low-MW to a high-MW form that also sedi-
mented to the bottom of the sucrose gradient (Figure 6C, top).
An in vitro assay revealed that only the high-MW fractions were
capable of activating caspase-1 (Figure 6C, bottom). These
Figure 6. Preformed ASCPYD Fibers Convert Inactive ASC into an Active High-Molecular-Weight Form Capable of Downstream Signaling
(A) Electron microscopy of negatively stained recombinant ASCPYD protein.
(B) Extracts of 293T cells stably expressing NLRP3 and ASCFL-GFP were fractionated on a 20%–60% sucrose gradient cushion before and after Nigericin
treatment. Individual fractions were western blotted with an ASC-specific antibody (top) or incubated with procaspase-1-containing cell extract, followed by
western analysis of caspase-1 activation.
(C) Lysate from 293T cells stably expressing ASCFL-GFPwere incubated at 30C for 30min with or without ASCPYD fibers, followed by the same analysis as in (B).
(D) Lysate from 293T cells stably expressing ASCFL-GFP were incubated at 30C for 60 min with different amounts of ASCPYD fibers or NM fibers as indicated,
along with procaspase-1 containing cell extract, followed by western blot analysis for caspase-1 activation.
(E) Dilutions of lysate of 293T cells stably expressing ASCFL-GFP as in (D) were quantitatively compared to different amounts of ASCPYD fibers by western blotting
with an antibody specific to ASCPYD.
(F) 293T cells stably expressing flag-procaspase-1 C284A and ASC-GFP WT or R41A were transfected with an AIM2 expression plasmid or mock treated. ASC
was immunoprecipitated with a GFP antibody, and then coimmunoprecipitated flag-procaspase-1 was immunoblotted with a flag antibody.
(G) Lysate from (F) was fractionated on a 20%–60% sucrose gradient cushion followed by immunoblot analysis of each fraction with indicated antibodies.
See also Figure S5.
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results indicate that ASCPYD fibers converted native ASC into an
active, self-perpetuating, and high-molecular-weight polymer
similar to the one induced by activated NLRP3 in cells.
To further demonstrate the infectious properties of ASCPYD
fibers, we incubated substoichiometric amounts of ASCPYD
fibers with lysate from 293T cells expressing ASCFL-GFP, which
is not active by itself, at 30C for 60 min. All reactions were sup-
plemented with lysate from 293T cells stably expressing procas-
pase-1 as the substrate. Western blot analysis revealed that only
the combination of ASCPYD fibers with ASCFL-GFP, but not either
one alone, resulted in caspase-1 activation (Figures 6D and 6E).
Titration experiments showed that incubation of less than 0.2 ng
of ASCPYD fibers with 5 mg of ASCFL-GFP led to detectable
cleavage of procaspase-1. In contrast, incubation of 500 ng of
NM fibers with 5 mg ASCFL-GFP failed to activate caspase-1.
Taken together, these results suggest that a catalytic and self-
perpetuating polymerization of ASC governs inflammasome
activation.
To examine the consequence of ASC polymerization on down-
stream signaling, we probed the interaction between ASC and
procaspase-1 following AIM2 transfection. In lysate from 293T
cells stably expressing flag-caspase-1 C284A and ASC-GFP
WT or R41A, GFP immunoprecipitation revealed that only ASC-
GFP WT, but not R41A, was able to interact with procaspase-1
in an AIM2-dependent manner (Figure 6F). Furthermore, sucrose
gradient analysis indicated that, following AIM2 stimulation, only
ASC-GFPWT, but not R41A, formed high-molecular-weight par-
ticles, which recruited procaspase-1, suggesting ASC polymeri-
zation is necessary for procaspase-1 recruitment (Figure 6G).
A Conserved Fungal Pattern Recognition Receptor and
Death-Inducing Prion Functionally Replace NLRP3PYD
and ASCPYD in Inflammasome Signaling
In addition to Sup35, there are a number of other well-character-
ized fungal prions, of which HET-s from the filamentous fungus
Podospora anserina shares notable similarities with MAVS and
ASC. Unlike yeast prions, the prion form of HET-s functions
strictly in a gain-of-function manner that induces cell death.
Also unlike other yeast prions, it does not require Hsp104 and
the prion fibers fail to stain with the amyloid-binding dye
Thioflavin T (ThT) (Saupe, 2011). Similarly, MAVS and ASC also
switch into gain-of-function prions, which propagate indepen-
dently of Hsp104 in yeast (Figure S5A). The recombinant fibers
of their prion domains also do not stain with ThT, suggesting
they are not prototypical b-amyloids (Figure S5B).Figure 7. Conserved Fungal Pattern Recognition Receptor and Dea
Inflammasome Signaling
(A) Cartoon representations of the mammalian NLRP3 inflammasome signaling a
potential signaling interaction. The predicted HET-sPrD fold of NWD2 N-terminal
motifs in tandem. Asterisk indicates inactive HeLo domain.
(B) Cartoon representations of fusion proteins between NWD2/HET-s and NLRP
(C) Confocal microscopy images of 293T cells stably expressing HET-sPrD-ASC
indicated on the top of each image.
(D) 293T cells stably expressing NLRP3 or NWD2N30-NLRP3DPYD, along with pr
ASCDPYD. Following Nigericin treatment, secretion of mature IL-1b and expressio
(E) Model for ASC-dependent inflammasome signaling. Green rectangles denote
(F) Model for NWD2-mediated HET-S activation. Rectangles with white stripes d
See also Figure S6.In filamentous fungi, spontaneous cell fusion leads to cell
death only if one partner expressesHET-S, and the other harbors
the prion form of HET-s ([Het-s]), an allelic variant of HET-S that
shares the same prion domain. Specifically, upon cell fusion,
[Het-s] templates prion conversion of HET-S, which leads to a
conformational change in the HET-S HeLo domain that converts
it into a pore-forming toxin (Seuring et al., 2012). However, in the
presence of soluble (nonprion) HET-s, HET-S does not cause cell
death. The hypothesis that HET-s/S serves host defense func-
tions is supported by a recent bioinformatics analysis that
discovered that NWD2, encoded by a gene adjacent to the
HET-s/S locus, closely resembles mammalian NOD-like recep-
tors (NLR) such as NLRP3, and may function as a signaling
partner of HET-s/S (Daskalov et al., 2012). Similar to NOD-like
receptors, NWD2 harbors a C-terminal WD40 repeat, a middle
NACHT (or nucleotide-binding oligomerization) domain, and an
N-terminal domain predicted to be homologous to the Het-s/S
prion domain. Overall, the fungal NWD2 and HET-s pair is strik-
ingly similar to mammalian NLRP3 and ASC, both in terms of
organization and function (Figure 7A).
To determine whether NWD2 can induce HET-s polymeriza-
tion and whether the NWD2/HET-s pair is a possible fungal
counterpart to NLRP3 and ASC, we tested whether the
NWD2 N-terminal domain (NWD2N30) and HET-s prion domain
(HET-sPrD) can reconstitute inflammasome signaling (Figure 7B;
Table S3). After replacing ASCPYD with HET-sPrD, we stably ex-
pressed the fusion protein with a C-terminal EYFP tag in 293T
cells. We observed that HET-sPrD-ASCDPYD-EYFP was distrib-
uted diffusely throughout the cell. The localization pattern did
not change with the coexpression of NWD2N50 (used instead of
NWD2N30 to facilitate western blot analysis) or NLRP3 (Fig-
ure 7C). However, coexpression of NWD2N30-NLRP3DPYD
(NLRP3PYD replaced by NWD2N30) resulted in a striking redistri-
bution of HET-sPrD-ASCDPYD-EYFP to form a single perinuclear
focus in almost every cell, reminiscent of the previously
described ASC foci (Figure 7C). These results suggest that
NWD2N30 is necessary, but not sufficient, for HET-sPrD-ASCDPYD
prion conversion and suggest that the NACHT domain of NWD2
is required for its oligomerization and downstream signaling,
similar to the current model for NLRP3 activation. Next, we
generated cell lines stably expressing NLRP3 or NWD2N30-
NLRP3DPYD along with procaspase-1 and pro-IL-1b and trans-
fected either WT ASC or HET-sPrD-ASCDPYD into the two cell
lines. Nigericin treatment revealed that mature IL-1b (p17) was
only secreted in cells expressing WT NLRP3 and ASC orth-Inducing Prion Functionally Replace NLRP3PYD and ASCPYD in
nd fungal NWD2 signaling pathways. Dotted arrow indicates an unconfirmed
domain is indicated using a yellow stripe, whereas HET-sPrD harbors two such
3/ASC.
DPYD-EYFP and transfected NWD2N50, NLRP3, or NWD2N30-NLRP3DPYD as
ocaspase-1 and pro-IL-1b were transfected with either WT ASC or HET-sPrD-
n of indicated proteins were analyzed by western blotting.
ASCPYD in its prion form. See text.
enote HET-s/SPrD in its prion form. See text.
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NWD2N30-NLRP3DPYD and HET-sPrD-ASCDPYD, indicating that
each receptor specifically interacts with its cognate prion (Fig-
ure 7D). Together, these results suggest that fungi possess a
programmed cell death pathway that is mechanistically similar
to those in mammals (Figures 7E and 7F). Furthermore, the regu-
lated conversion of prion domain containing proteins (Het-s/S
and ASC) into their prion forms by pattern recognition receptors
(NWD2 and NLRP3) is a signal transduction mechanism
conserved from fungi to mammals.
DISCUSSION
In this report, we provide biochemical and genetic evidence
demonstrating that MAVS and ASC exhibit hallmarks of prions
in cells and in vitro, and prion conversion is inducible by their
respective upstream signaling proteins (Figures 7E and S6).
Based on previously published results and those presented
here, we propose the following model for ASC-mediated in-
flammasome signaling: (1) stimulation of NLRP3 or AIM2 induces
a conformational change that results in the oligomerization or
close apposition of their individual PYRIN domains; (2) these
oligomers, through PYRIN-PYRIN interactions, then recruit
multiple ASC proteins resulting in prion nucleation, which is
otherwise prevented from occurring spontaneously due to a
high-energy barrier; (3) ASC prions then rapidly template other
ASC molecules resulting in the formation of large polymers;
and (4) through CARD-CARD interactions, the ASC polymers
recruit multiple caspase-1 molecules, bringing them into
close proximity to induce their autocleavage and activation
(Figure 7E).
The mechanism of NWD2-mediated HET-s/S activation in
fungi likely resembles that of NLRP3-mediated ASC and
caspase-1 activation in mammals (Figure 7F). Following bind-
ing of its WD40 repeats to a putative ligand, NWD2 oligomeriza-
tion through its NACHT domain induces its N-terminal region
to form a b-solenoid fold, which in turn templates HET-S
into a prion form that converts the HeLo domain into a pore-
forming toxin. Alternatively, in cells expressing the allelic variant
HET-s, NWD2 activation induces stable prion formation
because HET-s contains an inactive HeLo domain, resulting in
a decoupling of prion formation from cell death. Nevertheless,
when [Het-s] cells fuse with cells expressing HET-S, the prion
then templates HET-S into the toxic form, leading to death of
the fused cell.
Prion-like Polymerization Is a Sensitive and Robust
Mechanism of Cell Signaling
A self-perpetuating mechanism of signal amplification ensures
an ultrasensitive response. This mechanism is in line with our
previous estimate that as few as 20 viral RNA molecules can
activate the RIG-I antiviral signaling cascade (Zeng et al.,
2010). Our finding of the prion-like polymerization of ASC pro-
vides a mechanism of sensitive inflammatory and cell death
response to certain thresholds of noxious agents. The existence
of other NLR and prion protein pairs across the fungal kingdom
suggests an evolutionary conserved mechanism of signal trans-
duction (Daskalov et al., 2012). In addition, recent studies have
indicated that proteins in necrosis signaling and NF-kB activa-1220 Cell 156, 1207–1222, March 13, 2014 ª2014 Elsevier Inc.tion also form large oligomers or even fibers (Li et al., 2012;
Qiao et al., 2013; Sun et al., 2004).
The properties of MAVS and ASC distinguish them from
nonprion polymer-forming proteins. The soluble forms of prion
proteins are energetically less stable than their corresponding
polymeric forms and are separated from these forms merely
by the high energy of nucleation. Once nucleation has been
achieved (i.e., through RIG-I or NLRP3 activation) energetically
downhill and thus irreversible polymerization ensues. The prion
states subsequently perpetuate independently of the nucleating
factors. Hence, a population is characterized by a bimodal
distribution of cells that each contains either the native or prion
form of the protein. In contrast, polymerization of nonprion
proteins is dynamic and reversible, and the distribution
between soluble and polymeric forms is typically regulated
by changes in their relative stabilities. The polymerization
of actin and tubulin, for example, are each regulated by nucle-
otide (ATP and GTP, respectively) binding and hydrolysis. In
those cases, the soluble and polymerized forms of the protein
are uniformly distributed within an individual cell and a
population.
Likewise, not all proteins that form oligomers are capable of
forming self-perpetuating polymers. For example, in Toll-like re-
ceptor signaling, the adaptor MyD88 forms a finite but ordered
helical structure known as theMyddosome that includes the pro-
tein kinases IRAK4 and IRAK2 (Lin et al., 2010). For caspase-2
activation, upstream proteins PIDD and RAIDD also form a fixed
complex named the Piddosome that is composed of seven
RAIDD DDs and five PIDD DDs, which then recruit and activate
caspase-2 (Park et al., 2007b). The structural and biophysical
differences that cause some DD superfamily members to form
open-ended polymers and others to form limited oligomers
remain to be elucidated.
Unique Features ofMAVSandASCasPrion-like Proteins
Since the ‘‘prion hypothesis’’ was first proposed more than two
decades ago, we have come to understand prions not only as
causative agents of debilitating diseases, but also as potentially
adaptive mechanisms for phenotypic diversification and infor-
mation storage (Holmes et al., 2013; Prusiner, 1982; Si et al.,
2010; True and Lindquist, 2000). However, prior to the discovery
of MAVS as a prion, beneficial prions were not known to exist in
mammals, where the first prion was discovered.
Here, we show that MAVS and ASC are two mammalian pro-
teins capable of switching into functional prions, which differ
from previously described prions in several important aspects.
First, the prion domains of both proteins are neither intrinsically
disordered nor rich in Q and N amino acids. Rather, they adopt
well-folded six a-helical bundle structures (Liepinsh et al.,
2003; Potter et al., 2008). Second, although most prions display
loss-of-function phenotypes, the prion forms of MAVS and ASC
signal in a gain-of-function manner. Mutations that abolish their
prion activities also abrogate their biological functions. Third,
previously described prion proteins generally acquire their prion
forms stochastically. In contrast, the nucleation of MAVS and
ASC prions is tightly regulated, contingent on heterotypic inter-
actions with upstream protein sensors. Last, other mammalian
prion-like proteins described to date reside in postmitotic or
rarely dividing neurons or myocytes. Remarkably, the kinetics of
MAVS and ASC prion propagation is sufficient to sustain the
prion state in rapidly dividing yeast cells. Despite these unusual
features, MAVSCARD and ASCPYD exhibit the cardinal hallmarks
of prions, including irreversible conversion to stable filamentous
structures, cytoplasmic multigenerational inheritance, and, most
importantly, an ability to template native molecules of the same
protein into self-perpetuating conformations. For both MAVS
and ASC, the tight regulation of nucleation followed by efficient
polymerization produces a highly sensitive and robust ‘‘digital’’
response to harmful insults. It is likely that signal transduction
through prion-like switches is also deployed in other biological
pathways.
EXPERIMENTAL PROCEDURES
Yeast Prion Assays
Strains constitutively expressing the indicated DD-Sup35C fusionswere trans-
formed with plasmids encoding DD-, RIG-I(N)-, NLRP3PYD-, AIM2-, or
NLRC4CARD-EYFP fusions driven from a GAL1 promoter. Selected individual
colonies (usually in triplicates or quadruplicates) were then grown to conflu-
ency in SD-ura media, followed by washing three times in water to remove re-
sidual glucose. Cells were then resuspended in either SD-ura (no induction) or
SG-ura (induction) for 2 days before being plated as indicated. After growth at
30C for 2–3 days, 1/4YPD plates were moved to 4C overnight and photo-
graphed the following day. SD-ade and SD-ura plates were photographed
after 3–6 days of incubation at 30C.
In Vitro ASC Activity Assay
293T cells transfected with indicated pcDNA3-ASC WT or mutant plasmids
were lysed in buffer D (see Extended Experimental Procedures for buffer com-
positions) and centrifuged at 20,0003 g for 15min. Approximately 50 mg of the
supernatant (S20) was mixed with 20 mg of lysate from 293T cells stably ex-
pressing procaspase-1 and pro-IL-1b in buffer D and incubated at 30C for
the indicated time. Indicated amounts of ASCPYD or NM fibers were incubated
with 50 mg of lysate (S20) from 293T cells stably expressing ASC-GFP and
20 mg of S20 from 293T cells stably expressing procaspase-1 in buffer D in a
final volume of 11 ml at 30C for 60 min.
Inflammasome Reconstitution Assay in Cells
Approximately 18 hr after transfection of 200 ng of ASCWT ormutant plasmids
into 293T cells stably expressing flag-NLRP3, procaspase-1, and pro-IL-
1b-flag in a 12-well plate, 10 mM Nigericin was added to culture media for 45
or 90 min. The culture supernatant was concentrated using a 5 kDa filter
followed by SDS-PAGE analysis. Cells were lysed in buffer E followed by
centrifugation at 500 3 g. The supernatant was subjected to SDS-PAGE and
immunoblotting analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2014.01.063.
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